搜索临床试验以:ELI-002 (Dose Escalation)
总计441个结果
-
EpicentRx, Inc.完全的
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.招聘中
-
Sunnybrook Health Sciences Centre招聘中
-
OncotherapeuticsMillennium Pharmaceuticals, Inc.终止
-
Urovant Sciences GmbHDasman Diabetes Institute; Ion Channel Innovations完全的
-
IRCCS Centro di Riferimento Oncologico della Basilicata未知
-
Shanghai Zerun Biotechnology Co.,LtdWalvax Biotechnology Co., Ltd.主动,不招人
-
University of Alabama at Birmingham终止
-
Oasis Pharmaceuticals, LLCMayo Clinic; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)招聘中
-
Shanghai Zerun Biotechnology Co.,LtdWalvax Biotechnology Co., Ltd.主动,不招人
-
InQpharm Group完全的
-
Alfonso Gomez-IturriagaHospital de Cruces未知
-
Belgian Inflammatory Bowel Disease Research and...Janssen Cilag N.V./S.A.招聘中
-
Belgian Inflammatory Bowel Disease Research and...Janssen Cilag N.V./S.A.主动,不招人
-
Grünenthal GmbH完全的
-
Centre Georges Francois Leclerc完全的Advanced Rectal Cancers法国
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止骨髓增生异常综合征后伴多系发育不良的急性髓系白血病 | 成人急性微分化髓性白血病 (M0) | 未成熟的成人急性成髓细胞白血病 (M1) | 伴有 11q23 (MLL) 异常的成人急性髓性白血病 | 伴有 Del(5q) 的成人急性髓性白血病 | 成人急性髓性白血病伴 t(16;16)(p13;q22) | 成人红白血病 (M6a) | 成人纯红细胞白血病 (M6b) | 继发性急性髓性白血病 | 缓解期成人急性髓性白血病 | 成人急性早幼粒细胞白血病 (M3) | 成人急性髓性白血病伴 t(15;17)(q22;q12)美国
-
Boehringer Ingelheim完全的
-
University Hospital, Basel, Switzerland尚未招聘
-
Janssen-Cilag International NV完全的
-
University Hospital, GhentBelgian Federation Against Cancer完全的
-
Azura OphthalmicsThe University of New South Wales完全的
-
University of FloridaNational Heart, Lung, and Blood Institute (NHLBI)招聘中
-
Assistance Publique - Hôpitaux de ParisJanssen, LP完全的